MiR-223-3p in Cancer Development and Cancer Drug Resistance: Same Coin, Different Faces
Davide Barbagallo(University of Catania), Paola Campomenosi(University of Insubria), Antonino Bruno(University of Insubria), Rohit Gundamaraju(University of Tasmania), Donatella Ponti(Sapienza University of Rome), Shreya A. Akkihal, Jonahunnatha Nesson George-William(University of Milan), Barbara Bassani(MultiMedica), Laura Pulze(University of Insubria)
Cited by 27
Related Papers
CircSMARCA5 Regulates VEGFA mRNA Splicing and Angiogenesis in Glioblastoma Multiforme Through the Binding of SRSF1
|Cancers|2019|230
Myeloid Derived Suppressor Cells Interactions With Natural Killer Cells and Pro-angiogenic Activities: Roles in Tumor Progression
|Frontiers in Immunology|2019|212
CircSMARCA5 Inhibits Migration of Glioblastoma Multiforme Cells by Regulating a Molecular Axis Involving Splicing Factors SRSF1/SRSF3/PTB
|International Journal of Molecular Sciences|2018|193
Gut Microbial Changes, Interactions, and Their Implications on Human Lifecycle: An Ageing Perspective
|BioMed Research International|2018|142